0000950170-24-059787.txt : 20240514
0000950170-24-059787.hdr.sgml : 20240514
20240514171613
ACCESSION NUMBER: 0000950170-24-059787
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240510
FILED AS OF DATE: 20240514
DATE AS OF CHANGE: 20240514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lemaitre Dan
CENTRAL INDEX KEY: 0001478479
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 24945731
MAIL ADDRESS:
STREET 1: 2 MUSICK
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
ownership.xml
4
X0508
4
2024-05-10
0001237831
GLOBUS MEDICAL INC
GMED
0001478479
Lemaitre Dan
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
true
false
false
false
false
Class A Common Stock
2024-05-10
4
M
false
17500
43.77
A
28300
D
Class A Common Stock
2024-05-10
4
M
false
17500
43.58
A
45800
D
Class A Common Stock
2024-05-10
4
M
false
17500
53.27
A
63300
D
Class A Common Stock
2024-05-10
4
S
false
63300
64.6133
D
0
D
Stock Option (Right to Buy Class A Common Stock)
43.77
2024-05-10
4
M
false
17500
0
D
2028-01-22
Class A Common Stock
17500
0
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2024-05-10
4
M
false
17500
0
D
2029-01-22
Class A Common Stock
17500
0
D
Stock Option (Right to Buy Class A Common Stock)
53.27
2024-05-10
4
M
false
17500
0
D
2030-01-22
Class A Common Stock
17500
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.80 to $64.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
These options were granted on January 22, 2018 and are fully vested.
These options were granted on January 22, 2019 and are fully vested.
These options were granted on January 22, 2020 and are fully vested.
/s/ Kelly G. Huller, Attorney-in-Fact
2024-05-14